Funding for this research was provided by:
Bristol Myers Squibb
Article History
Received: 17 April 2021
Accepted: 10 October 2021
First Online: 26 November 2021
Declarations
:
: TI, MO, KS, and HV are employees and shareholders of Bristol Myers Squibb.
: All studies were conducted in accordance with the Declaration of Helsinki and the International Conference on Harmonisation Guidelines for Good Clinical Practice. The Institutional Review Board committee at each study center approved the study protocol.
: In all studies, patients provided written informed consent to participate.
: Not applicable.